09-07-2022 | Vaccination | Research Letter
Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients
Authors:
Ori Wand, Yael Einbinder, Naomi Nacasch, Tamar Halperin, Daniel Erez, Ayelet Grupper, Sydney Benchetrit, Michael Lishner, Amir Bar-Shai, Moshe Shashar, Keren Cohen-Hagai
Published in:
Journal of Nephrology
|
Issue 1/2023
Login to get access
Excerpt
Widespread vaccination has led to a reduced incidence of COVID-19. However, the combined effect of declining effectiveness over time and the emergence of highly transmissible variants of concern, led to breakthrough infections among vaccinated individuals [
1]. A third dose of the BNT162b2 (Pfizer-BioNTech) vaccine was effective in reducing SARS-CoV-2 infections and severe COVID-19 [
1]. …